Chief Financial Officer
Luc Van Fraeyenhoven joined Biotalys in August 2025. With more than three decades in financial roles, he brings significant experience as a CFO in the biotechnology and medtech industries. Luc has a strong background leading finance operations and strategy in addition to partnering closely with the boards of various companies throughout his career.
Previously, he has served as the CFO for Arseus Medical, ActoBio Therapeutics, the Akkermansia Company, and most recently with the Kebony Group. He also has extensive prior finance leadership experience with Volvo Cars, serving in roles of increasing responsibility including as CFO for the commercial entity in Europe.